In the present study, three animal models, including C57BL/6J mice, low-density lipoprotein receptor knockout (LDLR −/− ) mice, and rabbit that mimicked atherosclerosis, were established to investigate the inhibitory effect of oleanolic acid (OA) on atherosclerosis. In rabbit model, serum total cholesterol (TC), triglyceride, low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C) were measured. Carotid artery lesions were isolated for histological analysis. The red oil O and hematoxylin-eosin staining in liver were examined. The messenger ribonucleicacid (mRNA) levels of PPARγ, AdipoR1, and AdipoR2 related to lipid metabolism were determined. Compared with model group, OA and atorvastatin significantly lowered the levels of TC and LDL-C. The result of red oil O staining showed that OA and atorvastatin had similar effect on reducing the accumulation of lipid. Histological result demonstrated that OA reduced the thickness of intima. AdipoR1 was markedly increased, while AdipoR2 was remarkably decreased in OA group compared with that in the control group of the rabbit model. In LDLR −/− mouse model, lipid parameters in blood and mRNA levels of PPARγ, AdipoR1, and AdipoR2 were measured. It was found that OA exhibited similar effects as atorvastatin including reduced TG, LDL-C, and enhanced HDL-C. Notably, OA elevated the levels of AdipoR1 and PPARγ. At the same time, OA decreased TC and LDL-C in C57BL/6J mice model. Our results in three different animal models all revealed that OA retarded the development of atherosclerosis by influencing serum lipid levels, lipid accumulation in liver and intimal thickening of artery. And the underlying mechanism of OA on atherosclerosis may involve in lipid metabolism genes: PPARγ, AdipoR1, and AdipoR2.
Introduction
Atherosclerosis is a complex process which is heavily influenced by plasma lipoproteins, genetics, and hemodynamics of the blood flow in the artery, and there is no single ideal animal model that can entirely replicate the stage of human atherosclerosis so far [1] . Efforts have been made to develop different animal models to better understand human atherosclerosis. However, each animal model has its own advantages and disadvantages [2] . Therefore, a number of animal models have been constructed to better understand the mechanism of atherosclerotic lesions.
It is well known that atherosclerosis which is located in intima of many middle sized and large arteries is the underlying cause of most cardiovascular diseases (CVDs), including myocardial infarction, heart failure, stroke, and claudication [3, 4] . Large clinical trials have demonstrated that those diseases lead to high morbidity and mortality. Atherosclerosis is believed to be caused by passive lipid permeated into arterial wall and then covered by smooth muscle and endothelial cells, subsequently dynamic accumulation of oxidized cholesterol over time [5] . Many components are involved in this process such as oxidized low density lipoprotein (LDL), dead cells, heat shock proteins, and inflections. Although which component plays a major role in the development of atherosclerosis still remains controversial, much attention has been paid to oxidized LDL because of its abundant accumulation in lesions [6] [7] [8] . Statins, which can inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase, a reductase in cholesterol biosynthesis, are accepted as a successful medicine for atherosclerosis through reducing total cholesterol (TC), LDL-C, and triglycerides (TGs), and at the same time slightly elevating high density lipoprotein cholesterol (HDL-C) [9] .
Oleanolic acid (OA) is the active component from the leaves and roots of oleaceae, a traditional Chinese herb. It is a pentacyclic triterpenoid compound (3β-hydroxyolean-12-en-28-oic acid; Fig. 1 ) with various biological functions, such as hepato-protective effects, anti-inflammatory effects, and anticancer activities [10] [11] [12] [13] [14] . OA has also been demonstrated to have antiatherogenic effect [15] . Those properties make OA a promising candidate to inhibit atherosclerosis. In the present study, we investigated the effect of OA on atherosclerosis in three different animal models.
Materials and Methods

Materials
OA was purchased from Energy Chemical (Shanghai, China). Atorvastatin was purchased from Merro Pharmaceutical (Dalian, China). Atorvastatin is competitive inhibitor of HMG-CoA reductase that is used to lower lipid level. Hence, atorvastatin was selected as the active drug control.
Animals
New Zealand rabbits (weighing 2.0-2.5 kg) were purchased form Nanjing Jingling Rabbit Breeding Farm (Nanjing, China 
Experimental designs
Rabbits were randomly divided into 4 groups (8 rabbits in each group). The control group rabbits were fed with normal diet for 12 weeks and rabbits in the other three experimental groups were fed with atherogenic diet (1% cholesterol, 5% axungia porci, and 5% yolk powder). C57BL/6J mice were randomly divided into 4 groups (8 mice in each group). The control group mice were fed with normal diet, and mice in other experimental groups were fed with atherogenic diet. LDLR −/− mice were randomly divided into 3 groups (8 mice in each group) and fed with atherogenic diet. Animals were allowed free access to water. The rabbits of four experimental groups were anesthetized with 4% chloralic hydrate ip. Rabbits were incised on the skin and exposed the right carotid artery, then a 2.0 F arterial embolectomy catheter (pre-infiltrated with 1:15 heparin:normal saline) was inserted into a 3 cm-long segment of the bifurcation of the right carotid artery. About 0.1-0.2 ml gas was injected until full expansion to slight resistance and uniformly the balloon was pulled back to bifurcation. This process was repeated three times. After the model was established (6 weeks after induction of the injury), the rabbits were named as the control group (n = 8), model group (vehicle, n = 8, i.g.), atorvastatin group (2.5 mg/kg; n = 8, i.g.), OA group (10 mg/kg; n = 8, i.g.), which were subject to the corresponding treatment for 5 weeks to investigate the influence of OA and atorvastatin on atherosclerosis. The vehicle is 0.5% carboxyl methyl cellulose sodium.
In the C57BL/6J mice, the control group (n = 8) were treated with normal diet for 5 weeks, while the other 3 experimental groups were model group (vehicle; n = 8, ig), atorvastatin group (10 mg/kg; n = 8, i.g.), and OA group (25 mg/kg; n = 8, i.g.), which were subject to the corresponding treatment for 5 weeks.
For the LDLR −/− mice, the vehicle control group (vehicle; n = 8, i.g.),
atorvastatin group (10 mg/kg; n = 8, i.g.), and oleanolic group (25 mg/kg; n = 8, i.g.) were subject to the corresponding treatment for 5 weeks.
Measurement of blood parameters
Rabbit blood sample were collected from central ear artery before rabbits were sacrificed. After standing for 1 h at room temperature, samples were centrifuged at 500 g for 10 min at 4°C. Serum was separated and stored at −80°C until analysis. Blood sample was also harvested by retro-orbital bleed from C57BL/6J mice and LDLR −/− mice.
Serum TC, TG, LDL-C, and HDL-C were analyzed by enzymatic endpoint methods (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
Histology of liver tissue and artery in rabbit
Liver tissue and artery of rabbits were fixed with 4% paraformaldehyde for 1 day and embedded in paraffin. Liver tissue was examined by oil red O staining with hematoxylin as the counterstain. Artery was examined with hematoxylin-eosin staining. Digital micrographs of sections were captured under an Olympus IX-81 microscope (Tokyo, Japan).
Reverse transcriptase-polymerase chain reaction analysis
Total ribonucleicacid (RNA) was extracted from the liver tissue of rabbits and LDLR −/− mice by the Trizol universal reagent (Tiangen, Beijing, China) according to the manufacturer's instructions. Complementary DNA (cDNA) synthesis was performed by reverse transcription of total RNA with cDNA reverse transcription kit (TaKaRa, Dalian, China). cDNA was amplified with the specific polymerase chain reaction (PCR) Thermal Cycler Diec ® Real Time System (TaKaRa) in the presence of specific primers. Primer sequences in rabbit and mice are shown in Tables 1 and 2 , respectively. GAPDH was used as an internal control.
Statistical analysis
Data were expressed as the mean ± standard deviation (SD), and statistical analysis among groups were performed by unpaired Student's t-test and analyzed by Graphpad Prism software. P values <0.05 were considered as statistically significant.
Results
OA contributes to improve lipid parameters in blood and influence mRNA expression in rabbits
The lipid levels in serum were measured and shown in Fig. 2 . Notably, OA could dramatically reduce TC, TG, and LDL-C, but had little effect on HDL-C level compared with that of the model group. OA showed similar effect when compared with atorvastatin ( Fig. 2A-D) . Both OA and atorvastatin significantly elevated messenger RNA (mRNA) levels of AdipoR1. Interestingly, atorvastatin increased the level of AdipoR2 and PPARγ, while OA decreased the level of AdipoR2 (Fig. 2E-G) .
OA alleviates the level of lipid in liver and artery in rabbits
The oil red O staining of liver tissue of rabbits indicated that OA and atorvastatin significantly lower the accumulation of lipid compared with control (Fig. 3A) .
The histological analysis with hematoxylin-eosin staining showed that the artery in model group was characteristic by the incidence of vacuoles formation, and the intima was significantly thickened. However, OA group and atorvastatin group clearly showed decreased formation of vacuoles (Fig. 3B) , and the artery cellular morphology were nearly similar to that of control group fed with normal diet (Fig. 3B) .
OA changes the level of plasma cholesterol and regulates the expression of metabolic genes in LDLR −/− mice In LDLR −/− mice, serum TG and LDL-C (Fig. 4B,D) in OA group were significantly reduced and HDL-C (Fig. 4C) was markedly increased when compared with that of the control. It should be noted that the OA was more effective on TG than atorvastatin (Fig. 4B) . In the liver of LDLR −/− mice, the beneficial effects of OA on metabolism parameters were reflected by its influence on gene expressions that were involved in cholesterol biosynthesis. To our surprise, OA could remarkably elevate the mRNA levels of AdipoR1 and PPARγ, while atorvastatin seemed to have no effects on the expressions of those two genes (Fig. 4E,G) . Those trends indicated that OA regulates metabolism-related genes in liver, which may directly lower lipid levels and slow the development of atherosclerosis.
OA affects the lipid level in mice fed with high fat
To investigate the effect of OA on high fat-fed mice, the level of lipid in blood was also measured and the result showed that OA could significantly reduce the levels of TC and LDL-C (Fig. 5) . It seemed that OA did not affect the TG and HDL-C levels.
Discussion
Mouse model is the most frequently employed animal model because of its well-known genetic background, easy to breed and low cost of maintenance. However, plasma lipoprotein profiles and response to dietary cholesterol in mice are different from human. Genetically, modified mouse model which need dietary cholesterol is necessary to develop atherosclerosis with elevated levels of circulating cholesterol-rich LDL and very low density lipoprotein particles [16] . Rabbit is the most sensitive to dietary cholesterol overload and shares several aspects of lipoprotein metabolism with human. Several characteristics of rabbit make it a perfect animal model to study atherosclerosis. However, they have lower serum level of hepatic lipase and are lack of apoA-II [17] [18] [19] . Different animal models are useful to study different aspects in the process of atherosclerosis. In this study, C57BL/6J mice, LDLR −/− mice, and rabbit models were used to investigate the effect of OA. The word 'atherosclerosis' was first coined by French pathologist Jean Lobstein in 1829 [9] . Many reports agree that atherosclerosis is associated with the rising level of LDL-C in the blood, which deposited on the middle and large-sized arteries [20, 21] . LDL-C is usually modified into oxidized low density lipoprotein (OxLDL) by oxidation and enzymatic modification. OxLDL scatters within the atheroma, and high concentration OxLDL is toxic and may be a reason for cell death in the lesion [22] [23] [24] . Therefore, OxLDL may contribute to atherogenesis [25, 26] . In C57BL/6J mice, LDLR −/− mice and rabbits, the reduction of serum LDL-C under OA treatment was conspicuous. It implicated that OA was effective to inhibit the progression of atherosclerosis. Our present study also showed the effects of OA on serum TG, TC, and HDL-C in different animal models. Atherosclerosis is the basic pathology of CVDs, such as coronary heart disease, cerebrovascular stroke, and heart failure. These diseases are the leading cause of death in the world. This study shows the inhibitory effect of OA on the development of atherosclerosis, which presents a new application of OA [27, 28] . Furthermore, our results also demonstrated that OA could reduce the accumulation of lipid in liver tissue. OA-treated rabbits showed markedly lowered hepatic lipid contents when compared with rabbits in the model Table 1 . Primers used for real-time qPCR in rabbits
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group, which is similar to the atorvastatin-treated rabbits. It indicated that OA had therapeutic effects on disease of liver lipid accumulation.
To investigate possible mechanism of OA on atherosclerosis, the mRNA levels of PPARγ, AdipoR1, and AdipoR2 were measured.
PPARγ is nuclear receptor family of ligand-activated transcription factors, which balance glucose and lipid metabolism [29, 30] . It has been reported that PPARγ can reduce atherosclerosis via metabolic effect and directly affect the vessel wall. Atherosclerosis is also thought to be a chronic inflammatory condition, and PPARγ can also inhibit the expressions of some pro-inflammation genes [31] . So PPARγ may be an attractive target for anti-atherosclerosis therapy. In LDLR −/− mice, OA could significantly increase the expression of PPARγ. Furthermore, adiponectin has beneficial effects on CVDs through adiponectin receptors, AdipoR1 and AdipoR2. However, AdipoR1 and AdipoR2 play opposite roles in regulating glucose and energy metabolism. AdipoR2 −/− mice showed protective effects against the development of atherosclerosis [32, 33] . In rabbits and LDLR −/− mice, the relative mRNA expression of AdipoR1 was significantly increased in OA group. While in OA group, the relative mRNA expression of AdipoR2 was markedly decreased in rabbit model. Therefore, OA may slow the progression of atherosclerosis through the downregulation of AdipoR2 and simultaneously the upregulation of PPARγ and AdipoR1. OA may inhibit the progression of atherosclerosis and some researchers have demonstrated that OA may also be effective for the treatment of non-alcoholic fatty liver disease [34] , which corresponds with our results. The influence of OA on atherosclerosis could be complex, and the precise mechanism needs to be explored by future studies.
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